Kasaragod, Vikram Babu
Malinauskas, Tomas http://orcid.org/0000-0002-4847-5529
Wahid, Ayla A. http://orcid.org/0000-0001-8128-9632
Lengyel, Judith
Knoflach, Frederic
Hardwick, Steven W. http://orcid.org/0000-0001-9246-1864
Jones, Charlotte F.
Chen, Wan-Na
Lucas, Xavier
El Omari, Kamel http://orcid.org/0000-0003-3506-6045
Chirgadze, Dimitri Y. http://orcid.org/0000-0001-9942-0993
Aricescu, A. Radu http://orcid.org/0000-0003-3783-1388
Cecere, Giuseppe
Hernandez, Maria-Clemencia http://orcid.org/0000-0003-1621-4188
Miller, Paul S. http://orcid.org/0000-0002-6512-9441
Article History
Received: 28 February 2023
Accepted: 20 September 2023
First Online: 30 October 2023
Competing interests
: Flumazenil, bretazenil, diazepam, RO4938581, basmisanil, RO7015738, RO7172670, RO154513 and RO5211223, are compounds developed by F. Hoffmann-La Roche Ltd. J.L., F.K., X.L., G.C. and M.-C.H. were employees of F. Hoffmann-La Roche Ltd at the time these studies were performed. A.A.W., W.-N.C. and P.S.M. performed consultancy work for F. Hoffmann-La Roche Ltd at the time these studies were performed. The remaining authors declare no competing interests.